Daniel Podzamczer
Prevalence and clinical management of the neurocognitive disorders in the HIV-infected population.
Read more
Daniel Podzamczer
Comparative Neuropsychiatric Profile of Dolutegravir and Efavirenz after 48w in treatment naïve patients: Data from ING114467 SINGLE study.
Read more
José A. Muñoz-Moreno | Daniel Podzamczer
Management of Neurocognitive Impairment in HIV Patients: Recommendations from the Recently Published Spanish Guidlines (GESIDA 2013).
Read more